Recent Company News

• 08:58 AM ET Jul 22, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:36 AM ET Jul 23, 2025
  

  Street Takeaways - Lonza Group H1 earnings (CHF 573.20, +18.20)

• 07:33 AM ET Jul 23, 2025
  

  Johnson & Johnson announces European Commission (EC) has approved an indication extension of IMBRUVICA (ibrutinib) in frontline mantle cell lymphoma (MCL) ($167.93, 0.00)

• 06:56 AM ET Jul 23, 2025
  

  Autos/parts, healthcare and banks higher; tech and defensives main laggards:

• 04:27 AM ET Jul 23, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:58 AM ET Jul 23, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:10 AM ET Jul 23, 2025
  

  StreetAccount Metrics Recap - Lonza Group H1 Earnings (CHF 555.00, 0.00)

• 12:42 AM ET Jul 23, 2025
  

  Lonza Group reports H1 core EPS CHF7.51 vs consensus CHF7.22

• 05:07 PM ET Jul 22, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market